As state authorities begin to ease restrictions imposed by COVID-19, physicians, nurse leaders, and administrators face a momentous challenge: resuming elective surgical procedures that have been postponed for several weeks or months. How will they accommodate the looming glut of elective surgery demand with limited infrastructure and staff who are…
Editor's Note More than 28 million elective surgical procedures worldwide will be cancelled or postponed as a result of the COVID-19 pandemic, this study estimates. Researchers from the University of Birmingham, UK, collected data from surgeons in 359 hospitals and 71 countries. The data was then statistically modeled to estimate…
Editor's Note The Centers for Medicare & Medicaid Services (CMS) on May 11 released a proposed rule that increases Medicare inpatient prospective payment system (IPPS) rates by a net of 3.1% in FY 2021, compared to 2020, for acute care hospitals participating in the Hospital Inpatient Quality Reporting Program that…
Editor's Note In this study, researchers at the Massachusetts General Hospital, Boston; King’s College, London; and health science company Zoe Global, Accra, Ghana; developed an artificial intelligence (AI) diagnostic that can predict whether someone is likely to have COVID-19 based on their symptoms. The researchers analyzed data from 2,618,862 people…
Federal regulators have yet to mandate electronic health record (EHR) adoption at ambulatory surgery centers (ASCs). Many facilities remain content to use paper systems. However, one expert advocates preparing now for what may come in the future. Electronic documentation systems can help ASCs better achieve their clinical, financial, operational, and…
Editor's Note Treating hospitalized COVID-19 patients with anticoagulants may improve their chances of survival, this study from Mount Sinai finds. Of 2,773 COVID-19 patients analyzed, 786 received a full-treatment dose of anticoagulants, which was a higher dose than that typically given for clot prevention; it is one usually given to…
Editor's Note Researchers at Northwestern University in Chicago are using artificial intelligence (AI) to expedite the search for COVID-19 treatments and vaccines by shortening the expert review period. The AI tool prioritizes research that has the most potential to produce real solutions and ignores research that is unlikely to yield…
Editor's Note The spread of COVID-19 in the US could result in hundreds of billions of dollars in direct medical costs, according to this study partially funded by the Agency for Healthcare Research and Quality (AHRQ). Using AHRQ data and other sources, researchers developed computer models to simulate the financial…
Editor's Note An artificial intelligence (AI) tool that analyzes CT scans of the chest was 75% accurate in determining COVID-19 patients who required ventilators, the April Radiology Business reports. Researchers at Cleveland’s Case Western Reserve University built the tool using scans and datasets from the web, COVID-19 chest images from…
Editor's Note: A research team led by the University of Singapore has developed an artificial intelligence (AI) platform called, “IDentif.AI” (Indentifying Infectious Disease Combination Therapy with Artificial Intelligence) to increase efficiency in the development of treatments that combine several different drugs. The researchers selected 12 drugs that are viable candidates…